In this study, we tested the role of colony-stimulating factor 2 (CSF2) as one of the regulatory molecules that mediate maternal effects on embryonic development during the preimplantation period. Our objective was to verify effects of CSF2 on blastocyst yield, determine posttransfer survival, and evaluate properties of the blastocyst formed after CSF2 treatment. In vitro, CSF2 increased the percentage of oocytes that became morulae and blastocysts. Blastocysts that were treated with CSF2 tended to have a greater number of inner cell mass cells and had a higher ratio of inner cell mass to trophectoderm cells. There was no effect of CSF2 on the incidence of apoptosis. Treatment with CSF2 from d 5 to 7 after insemination increased embryonic survival as indicated by improved pregnancy rate at d 30 -35 of gestation. Moreover, treatment with CSF2 from either d 1-7 or 5-7 after insemination reduced pregnancy loss after d 30 -35. Results indicate that treatment with CSF2 can affect embryonic development and enhance embryo competence for posttransfer survival. The fact that treatment with CSF2 during such a narrow window of development altered embryonic function much later in pregnancy suggests that CSF2 may exert epigenetic effects on the developing embryo that result in persistent changes in function during the embryonic and fetal periods of development. (Endocrinology 150: 5046 -5054, 2009) 
T
he embryo executes its developmental program in the female reproductive tract in an environment largely dictated by the mother. An inadequate maternal environment can lead to reduced embryonic survival (1) (2) (3) and epigenetic changes that persist into adulthood (4) . The maternal environment affects embryonic development by providing to the embryo an array of nutrients and signaling molecules and by expression of cell adhesion molecules that facilitate eventual attachment and placentation (5) . Among the signaling factors shown to affect preimplantation development in the cow, for example, are IGF-I (6), IL-1␤ (7), activin (8) , and colony stimulating factor 2 (CSF2) (i.e. granulocyte-macrophage colony stimulating factor) (9) .
There are strong lines of evidence to implicate CSF2 as a physiologically important regulator of early embryonic development. The cytokine is expressed in luminal epithelium and other tissues of the oviduct and endometrium (10 -14) . In mice, production of CSF2 fluctuates during the estrous cycle, peaking during estrus (15) . Release of CSF2 into the uterine lumen is stimulated by specific factors in seminal plasma, including TGF-␤ (16) . In cattle, immunoreactive CSF2 in the endometrium of cyclic cows tends to be low during estrus and high from d 13 to 17 after estrus before declining as the next estrus approaches (12, 14) . Addition of CSF2 to culture medium improved the proportion of embryos developing to the blastocyst stage in the cow (9) , human (17) , and pig (18) and increased posttransfer embryonic survival in mice (19) . Total cell numbers of blastocysts from Csf2 Ϫ/Ϫ mice were reduced by 14 -18% compared with wild-type controls (13) . Despite a regular number of implantation sites, offspring from Csf2 Ϫ/Ϫ mice were 25% of normal size, exhibited fetal growth retardation, and experienced increased mortality during the first 3 wk of life (20, 21) . The bovine preimplantation embryo is a good model for studying maternal regulation of embryonic development. Development to the blastocyst stage is not absolutely dependent on regulatory molecules present in the reproductive tract because embryos produced in growthfactor free culture media can give rise to live calves after transfer to recipients (22) . However, embryos produced by in vitro oocyte maturation, fertilization, and culture have aberrant biochemical and molecular properties when compared with those produced in vivo (23, 24) . Deviation in embryonic function associated with production in vitro is due in part to an inadequate environment during the preimplantation period. This is SO, because the gene expression and cryotolerance of bovine embryos produced by in vitro fertilization was enhanced when embryos were cultured in vivo in the sheep oviduct after insemination (23, 25) .
Here we tested the possible role of CSF2 as one of the regulatory molecules that mediate maternal effects on embryonic function during the preimplantation period. The objective was to test the hypothesis that addition of CSF2 to culture medium would enhance development and posttransfer survival of bovine embryos produced in vitro. As a positive control, some embryos were treated with IGF-I, which to date is the only growth factor shown to improve survival of bovine embryos transferred to recipients. This molecule protects embryos from the effects of elevated temperature (26, 27) , and pregnancy and calving rate of cows exposed to heat stress were improved when embryos used for transfer were treated with IGF-I (22, 28) . However, no improvement in posttransfer survival was seen when cows were not heat stressed (22) .
Materials and Methods

Materials
The media HEPES-Tyrode's lactate (TL), in vitro fertilization (IVF)-TL, and sperm-TL were purchased from Caisson (Sugar City, ID) and used to prepare HEPES-Tyrode's albumin lactate pyruvate (TALP) and IVF-TALP as previously described (29) . Oocyte collection medium was tissue culture medium-199 with Hanks' salts without phenol red (Hyclone, Logan UT) supplemented with 2% (vol/vol) bovine steer serum (Pel-Freez, Rogers, AR) containing 2 U/ml heparin, 100 U/ml penicillin-G, 0.1 mg/ml streptomycin, and 1 mM glutamine. Oocyte maturation medium was tissue culture medium-199 (Invitrogen, Carlsbad, CA) with Earle's salts supplemented with 10% (vol/vol) bovine steer serum, 2 g/ml estradiol 17-␤, 20 g/ml bovine FSH (Folltropin-V; Bioniche Life Sciences, Belleville, Ontario, Canada), 22 g/ml sodium pyruvate, 50 g/ml gentamicin sulfate, and 1 mM glutamine. Percoll was from Amersham Pharmacia Biotech (Uppsala, Sweden).
Potassium simplex optimized medium, bovine embryo modification 2 (KSOM-BE2) was prepared as described elsewhere (30) . Prostaglandin F 2␣ (PGF) was Lutalyse from Pfizer (New York, NY), and GnRH was Cystorelin from Merial (Duluth, GA). Dithiothreitol was from Sigma-Aldrich (St. Louis MO).
Recombinant bovine CSF2 was donated by CIBA-GEIGY (Basel, Switzerland). Recombinant human modified IGF-I (E3R) was obtained from Upstate Biotech (Lake Placid, NY).
Effects of CSF2 on embryo development and blastocyst properties
Production of embryos
Embryo production was performed in vitro as described (30) . Cumulus oocyte complexes (COCs) were obtained by slicing 2-to 10-mm follicles on the surface of ovaries (a mixture of beef and dairy cattle) obtained from Central Beef Packing Co. (Center Hill, FL). Those COCs with at least one complete layer of compact cumulus cells were washed two times in oocyte collection medium, placed in groups of 10 in 50-l microdrops of oocyte maturation medium overlaid with mineral oil and matured for 20 -22 h at 38.5 C in a humidified atmosphere of 5% (vol/vol) CO 2 in humidified air.
Matured COCs were transferred in groups of 50 to four-well plates containing 425 l of IVF-TALP and 20 l of 0.5 mM penicillamine, 0.25 mM hypotaurine, and 25 M epinephrine in 0.9% (wt/vol) NaCl per well and fertilized with about 1ϫ 10 6 Percoll-purified spermatozoa from a pool of frozen-thawed semen from three bulls. After 8 -10 h at 38.5 C in a humidified atmosphere of 5% (vol/vol) CO 2 in humidified air, putative zygotes were removed from fertilization wells, denuded of cumulus cells by vortexing in HEPES-TALP, and placed in groups of 30 in 50-l microdrops of KSOM-BE2. Putative zygotes were cultured at 38.5 C in a humidified atmosphere of 5% CO 2 or 5% CO 2 , 5% O 2 , and 90% N 2 .
Interactions between oxygen concentration and presence of CSF2
This experiment was designed to test whether effects of CSF2 on embryonic development seen earlier (9) under culture conditions of high oxygen [5% (vol/vol) CO 2 in air] would also be seen in low oxygen [5% CO 2 , 5% O 2 , and 90% N 2 (vol/vol)] when added at d 0 or 5 after insemination. After removal from fertilization drops, embryos were washed, placed in microdrops of KSOM-BE2 medium, and cultured in high O 2 or low O 2 . If treatment was d 0, embryos were placed in a 50 l KSOM-BE2 drop Ϯ 10 ng/ml CSF2. When treatment was at d 5, embryos were placed in a 45-l KSOM-BE2 drop, and 5 l of KSOM-BE2 Ϯ 10 ng/ml CSF2 were added to the drop at d 5 after insemination. The concentration was chosen based on results from other experiments that addition of CSF2 at this concentration would increase blastocyst yield (9, 31) . Cleavage rate was assessed at d 3 after insemination, and the percent of oocytes that became blastocysts was assessed at d 7 and 8 after insemination. The experiment was replicated 11 times using 2673 oocytes.
Cell number and differentiation of blastocysts
The experiment was designed to test whether CSF2 would increase cell number of bovine blastocysts and alter cell allocation between the trophectoderm (TE) and inner cell mass (ICM). After fertilization, embryos were cultured in 45 l microdrops of KSOM-BE2 at 38.5 C in a humidified atmosphere of 5% CO 2 , 5% O 2 , and 90% N 2 . At d 5 after insemination, 5 l of CSF2 (to create a final concentration of 10 ng/ml) or 5 l of vehicle (KSOM-BE2) were added to the drops. Zona-intact blastocysts were removed from culture at d 7, washed two times in 50-l microdrops of 10 mM KPO 4 (pH 7.4) containing 0.9% (wt/vol) NaCl and 1 mg/ml polyvinylpyrrolidone (PBS-PVP) by transferring the embryos from microdrop to microdrop and then examined for numbers of TE and ICM using procedures described elsewhere (32) . The experiment was replicated three times using 18 -36 embryos/group.
Apoptotic blastomeres
This experiment was designed to test the hypothesis that CSF2 decreases the percentage of blastomeres that are positive for the terminal deoxynucleotidyl transferase deoxyuridine 5-triphosphate nick end labeling (TUNEL) reaction. Embryos were cultured and treated with CSF2 as described above for analysis of TE and ICM. On d 7 after fertilization, blastocysts, expanded blastocysts, and hatching blastocysts were removed from culture and washed two times in 50-l microdrops of PBS-PVP. Embryos were fixed in a 50-l microdrop of 4% (wt/vol) paraformaldehyde in PBS for 15 min at room temperature, washed twice in PBS-PVP, and stored in 600 l of PBS-PVP at 4 C until analysis for TUNEL labeling as described previously (26, 27) . The experiment was replicated three times using 31-58 embryos/group.
Effects of CSF2 and IGF-I on pregnancy and calving success after transfer to recipients
Production of Holstein embryos using X-sorted semen
Embryo production was performed as described above with slight modifications. Holstein COCs were purchased from one of three suppliers (Evergen, Storrs, CT; Bomed, Madison, WI; Trans Ova, Sioux City, IA) and shipped overnight in a portable incubator at 38.5 C in maturation medium or collected from slaughterhouse ovaries. After 20 -22 h, COCs were removed from maturation medium, washed one time in HEPES-TALP, and transferred in groups of 30 to fertilization drops covered with mineral oil. Each drop contained 50 l IVF-TALP, and then 3 l 0.5 mM penicillamine, 0.25 mM hypotaurine, and 25 M epinephrine in 0.9% (wt/vol) NaCl and 20 l sperm purified by Percoll gradient were added to this. The final concentration of sperm was 1ϫ 10 6 /ml. For each replicate, two to four straws of X-sorted semen from one Holstein bull (Sexing Technologies Inc., Navasota TX) were used, depending on the number of oocytes that had to be fertilized. In total, four different bulls were used throughout the experiment.
After 20 -22 h at 38.5 C and 5% (vol/vol) CO 2 , presumptive zygotes were removed from fertilization drops, vortexed in 30 l HEPES-TALP for 5 min in a microcentrifuge tube, and washed two times to remove cumulus cells and associated spermatozoa. Putative zygotes (25-30/drop) were placed in 45 l (treatment at d 5) or 50 l (treatment at d 0) of KSOM-BE2 overlaid with mineral oil. Embryos were cultured at 38.5 C in a humidified atmosphere of 5% CO 2 , 5% O 2 , and 90% N 2 (vol/vol). Treatments were added at either d 0 (i.e. immediately after fertilization) or d 5 after fertilization as described for each experiment.
The proportion of oocytes that cleaved was recorded at d 3 after insemination. Morula, blastocyst, and expanded blastocyst stage embryos classified as grade 1 or 2 (33) were harvested on d 7 (farms 1 and 2) and d 8 (farm 3) and loaded into 0.25-ml straws in HEPES-TALP supplemented with 10% fetal calf serum and 50 M dithiothreitol. Straws containing selected embryos were then placed horizontally into a portable incubator (Cryologic, Mulgrave, Victoria, Australia) at 38.5 C and transported to the respective farm.
Animals
The protocol for care and use of animals was approved by the University of Florida Institutional Animal Care and Use Committee. The experiment was conducted at three locations: farm 1 (Quitman, GA; 30°47Ј5Љ N, 83°33Ј39Љ W); farm 2 
Synchronization and timed embryo transfer
Each week, eligible cows were organized into a group (i.e. replicate) and ovulation synchronized for embryo transfer. The timed ovulation protocol was the Ovsynch-56 procedure (34). Day 0 was considered the day of expected ovulation. Hormone treatments consisted of 100 g GnRH, im, on d Ϫ10; 25 mg PGF 2␣ , im, on d Ϫ3; and 100 g GnRH im at 56 h after PGF 2␣ . For first-service cows only, the timed ovulation protocol was preceded by a presynch protocol (two injections of 25 mg PGF 2␣ , im, 14 d apart), with the last injection 14 d before initiation of the timed ovulation protocol. Cows were diagnosed for the presence of corpus luteum at d 7 after anticipated ovulation using an Aloka 500 (Wallingford, CT) ultrasound equipped with a 5-MHz linear array transducer. Cows diagnosed with a corpus luteum were given epidural anesthesia [5 ml of 2% (wt/vol) lidocaine] and a single embryo transferred to the uterine horn ipsilateral to the ovary via the transcervical route.
Effect of CSF2 and IGF-I added at d 1 of culture on development and posttransfer survival of bovine embryos
The experiment was conducted from June 29 through August 31, 2007, at farm 1 in seven replicates. At d 1 after fertilization, presumptive zygotes were randomly distributed to 50 l KSOM-BE2 drops with one of three treatments: 1) KSOM-BE2 alone, 2) 10 ng/ml CSF2, or 3) 100 ng/ml IGF-I. Cleavage rate was assessed at d 3 after insemination. At d 7 after insemination, grade 1 or 2 morula, blastocyst, and expanded blastocyst stage embryos, considered transferable embryos, were harvested and transferred to lactating dairy cows synchronized using the Presynch/Ovsynch protocol. Pregnancy was diagnosed between d 30 and 35 of gestation using ultrasonography and the incidence of calving recorded. Transfers were performed for 51-55 cows/treatment.
Effect of CSF2 added at d 5 of culture and IGF-I added
ng/ml CSF2 was added to the drops to achieve a final concentration of 10 ng/ml CSF2. The remaining seven replicates used similar treatments except the control treatment was changed so that embryos were placed in 45-l drops of KSOM-BE2 at d 1 after insemination, and 5 l KSOM-BE2 were added to the drops at d 5 after insemination. Because there was no statistical difference between the two types of control embryos, control data were pooled. Cleavage rate was assessed at d 3 after insemination. At d 7 after insemination, grade 1 or 2 morula, blastocyst, and expanded blastocyst stage embryos were harvested and transferred to lactating dairy cows synchronized using the Presynch/Ovsynch-56 or Ovsynch-56 protocol. Pregnancy was diagnosed between d 30 and 35 of gestation using ultrasonography and the incidence of calving recorded. Transfers were performed for 44 -107 cows/treatment.
Statistical analysis
Data on the percent of oocytes that cleaved and that became blastocysts and transferable embryos, the percentage of cells that were TUNEL positive, and the ICM to TE ratio were analyzed by least-squares ANOVA using the general linear models procedure of SAS (SAS for Windows, version 9.0; SAS, Cary, NC). Data were transformed by arcsin transformation before analysis. The mathematical model included main effects and all interactions. Replicate was considered a random effect and other main effects were considered fixed. Tests of significance were made using error terms determined by calculation of expected mean squares. All values reported are least-squares means Ϯ SEM. Probability values are based on analysis of arcsin-transformed data, whereas least-squares means are from analysis of untransformed data.
Data regarding the percent of cows that were diagnosed as pregnant at d 30 -35 after transfer (i.e. pregnancy rate) and the percent of cows that calved (i.e. calving rate) were analyzed by logistic regression using the LOGISTIC procedure of SAS. Initial analysis indicated that effects of embryo stage, replicate, and farm were nonsignificant. These effects were removed from the model so that the only effect in the final model was treatment. Treatment effects were separated into individual degree of freedom comparisons using contrasts. Two sets of contrasts were compared. The first, testing the hypothesis that both CSF2 and IGF-I would increase pregnancy and calving rate, were control vs. IGF-I and CSF2 and IGF-I vs. CSF2. The second, testing the hypothesis that only CSF2 would increase pregnancy and calving rate, were control and IGF-I vs. CSF2 and control vs. IGF-I. An additional contrast was also made to compare control to CSF2. Data on the percent of pregnant cows at d 30 -35 that lost the pregnancy before term (i.e. pregnancy loss) were analyzed for the first and second experiment and for all the losses in both experiments by 2 analysis.
Results
Effects of CSF2 on embryo development
Overall, there was no effect of CSF2 on cleavage rate at d 3 after insemination, with averages varying from 73 to 80%. There was a tendency for CSF2 to increase the percent of oocytes that became blastocysts on d 7 after fertilization (P ϭ 0.09; Fig. 1, top panel) . Development was higher in low oxygen (P Ͻ 0.0001), but there was no interaction with day of treatment or oxygen concentration. On d 8 after insemination (Fig. 1, bottom panel) , CSF2 increased blastocyst development (treatment, P ϭ 0.05), development was greater in low oxygen (P Ͻ 0.0001), and there was a treatment ϫ day ϫ oxygen interaction (P ϭ 0.06). The observed three-way interaction between treatment, day, and oxygen is due to the fact that the difference in response to addition of CSF2 at d 0 vs. d 5 depended on oxygen concentration. For embryos cultured in low oxygen, CSF2 increased blastocyst development to a greater extent when added at d 5 rather than at d 0. For embryos in high oxygen, CSF2 increased blastocyst development to a greater extent when added at d 0.
Effects of CSF2 on blastocyst total cell number, cell differentiation, and apoptosis
As shown in Table 1 , blastocysts formed in the presence of CSF2 had a tendency for an increased number of ICM There was a tendency for CSF2 to increase the percentage of blastocysts at d 7 (treatment, P ϭ 0.09) and at d 8 (treatment, P ϭ 0.05; treatment ϫ day ϫ oxygen ϭ 0.06) when embryos were treated with CSF2. There was an effect of oxygen on the percentage of oocytes that became blastocysts at d 7 and 8 on both days of treatment (P Ͻ 0.0001).
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Effects of CSF2 and IGF-I on pregnancy and calving rate after transfer to recipients
In the first experiment, treatments were added at d 1 of culture and recipients were used in the summer during heat stress (Table 3) . There was an increase in the percentage of cleaved embryos that became a transferable morula or blastocyst on d 7 after insemination when embryos were treated with CSF2 (control vs. CSF2, P Ͻ 0.01; control and IGF vs. CSF2, P Ͻ 0.02; control vs. IGF and CSF2, P Ͻ 0.02; Table 3 ). Treatment did not have an effect on pregnancy rate at d 30 -35 of gestation or on calving rate, although, numerically, pregnancy and calving rates were higher in the IGF-I group than for the other two groups. Pregnancy loss between d 30 and 35 and term was lower for recipients that received a CSF2 treated embryo compared with control embryos (CSF2 vs. control, P Ͻ 0.05; CSF2 and IGF-I vs. control, P Ͻ 0.05; Table 3 ). Of the calves born, 85% were female.
The second experiment was conducted largely during the cool season. IGF-I was given to embryos at d 1 after insemination but CSF2 was added at d 5 of culture. Treatment with CSF2 was modified from the first experiment because of the failure of CSF2 treatment at d 1 to affect pregnancy rate (Table 3 ) and because of data indicating greater effects of CSF2 on development in low oxygen when added at d 5 (see Fig. 1 ). There was an increase in the percentage of cleaved embryos that became a transferable morula or blastocyst on d 7 after insemination when embryos were treated with CSF2 at d 5 of culture (CSF2 vs. control, P Ͻ 0.01; CSF2 vs. IGF, P Ͻ 0.01; CSF2 and IGF vs. control, P Ͻ 0.02; CSF2 vs. control and IGF, P Ͻ 0.02; Table 4 ). Moreover, pregnancy rate (CSF2 vs. control and IGF-I, P Ͻ 0.05; CSF2 vs. IGF, P Ͻ 0.06; Table 4 ) and calving rate (CSF2 vs. control, P Ͻ 0.05; CSF2 vs. control and IGF, P Ͻ 0.05; Table 4 ) were higher for cows receiving embryos treated with CSF2 than embryos receiving control or IGF-I-treated embryos. There was no significant effect of treatment on pregnancy loss, but pregnancy loss was numerically lower for cows receiving embryos treated with IGF-I or CSF2 than for cows receiving control embryos. Of the calves born, 85% were female.
When data from the two transfer experiments were pooled, the difference in pregnancy loss between cows receiving control embryos (nine of 40; 22.5%) and cows receiving either an embryo treated with either IGF-I (three of 36; 8.3%) or CSF2 (five of 62; 8.1%) was significant (P Ͻ 0.025).
Discussion
Experiments reported here implicate CSF2 as an important regulator of preimplantation development. Treatment with CSF2 increased the proportion of embryos that became blastocysts and the ICM/TE ratio and improved the survivability of embryos after transfer to recipients. The effect of CSF2 on posttransfer survival involved both an increase in the proportion of embryos that established pregnancy by d 30 -35 (when treatment was from d 5 to 7 after insemination) and a reduction in the proportion of embryos at d 30 -35 which were lost before completion of gestation (when treatment was from d 1-7 or 5-7 after insemination). The fact that treatment with CSF2 during such a narrow window of development (from d 1-7 or d 5-7) altered embryonic function much later in pregnancy (after pregnancy diagnosis at d 30 -35) suggests that CSF2 is exerting epigenetic effects on the developing embryo that result in persistent changes in function during the embryonic and fetal periods of development.
The likelihood that actions of CSF2 during the preimplantation period on survival after d 30 -35 represent modifications of the epigenome implies that CSF2 may be one of the molecules through which changes in maternal physiology lead to alterations in fetal programming. An example of the importance of maternal function for conceptus development is induction of fetal overgrowth in sheep by transfer of embryos into an advanced uterine environment (35) or premature elevation of progesterone concentrations (36) . Bovine embryos produced in vitro, Values are least-squares means Ϯ SEM. Replicates ϭ 3; n ϭ 31-58 embryos/group. Treatment effects were not significant.
which are not exposed to most of the regulatory molecules produced by the reproductive tract, are associated with an array of fetal abnormalities including increased rates of abortion, fetal overgrowth, and altered metabolism (24, 37, 38) . Maternal effects on conceptus development involve epigenetic alterations in DNA methylation patterns, as has been demonstrated for sheep exposed to nutritional stress (4) and embryos produced in vitro in cattle (39) . Treatment with CSF2 increased the proportion of embryos becoming blastocysts regardless of whether it was added immediately after fertilization or at d 5 after insemination (a time when embryos were at the morula stage of development). Similar results were seen in an earlier experiment with bovine embryos (9) . Thus, the action of CSF2 to increase the ability of embryos to advance to the blastocyst stage of development involves actions on the embryo during the transition from the morula to blastocyst stage of development. Perhaps CSF2 is mitogenic and increases the number of embryos that have cell numbers sufficient for blastocoele formation. Another possibility, that CSF2 increases cell number by blocking apoptosis, is less likely. Although culture of human embryos with CSF2 decreased the number of apoptotic blastomeres by 50% (40), no effect of CSF2 on apoptosis was observed in the present experiment. Alternatively, CSF2 could increase one or more of the molecules involved in blastocyst formation. The observation that blastocysts from CSF2-treated embryos had proportionally more ICM cells relative to TE indicates the capacity of CSF2 to affect blastocyst differentiation. In the human (40) and mouse (41) , CSF2 treatment in culture resulted in more cells in the ICM of blastocysts.
The magnitude of the effect of CSF2 on blastocyst yield depended on the timing of exposure and the oxygen concentration used for culture. For embryos cultured in low oxygen, the increase in blastocyst yield caused by CSF2 was greater when the cytokine was added at d 5 than at d 0. The opposite was true when embryos were cultured in high oxygen. Differences in response between d 0 and d 5 may reflect degradation of CSF2 during culture or downregulation of CSF2 receptors. The importance of oxygen as a determinant of the effect of timing of CSF2 precludes simple explanations, however.
The improvement in survival of embryos after transfer to recipients varied with timing of CSF2 exposure. In the initial experiment, in which embryos were exposed to CSF2 from d 1 to 7 after insemination, there was no effect of CSF2 on pregnancy rate at d 30 -35 of gestation. In the second experiment, however, when CSF2 treatment was from d 5 to 7 after insemination, pregnancy rate at d One action of CSF2 that might enhance survival after transfer is the increase in number of ICM cells in the blastocyst. In the mouse, CSF2 increased the number of ICM cells (41) and posttransfer survival of embryos (19) . In the mouse, the number of cells in the ICM correlates with viability after transfer (42) . The ICM to TE ratio for bovine embryos produced in vitro differs considerably from embryos generated in vivo (43) (44) (45) . Moreover, a high proportion of embryos produced in vitro have no detectable embryonic disc by d 14 of gestation (46, 47) . At d 16 of gestation, embryonic discs were reported to be smaller for embryos produced in vitro than embryos produced in vivo (48) . Perhaps CSF2 minimizes the detrimental effects of culture on embryonic disc development or survival by increasing the ICM to TE ratio.
Another way in which CSF2 might improve posttransfer embryonic survival at d 30 -35 of gestation would be through increased secretion of the anti-luteolytic pregnancy recognition signal interferon-by elongated embryos. At least 40% of total embryonic losses have been estimated to occur between d 8 and 17 of pregnancy (49) when the conceptus ordinarily inhibits pulsatile PGF 2␣ secretion. Treatment with CSF2 increased interferonproduction by elongated sheep embryos (50 -52) and a cell line derived from bovine trophoblast cells (53) . CSF2 could also affect expression of other genes. The production of embryos in vitro alters the expression of several developmentally important genes (23, 48, 54, 55) , and such alterations in gene expression can persist at least through d 25 of gestation (56) .
Treatment of embryos with IGF-I represents a positive control. This treatment has been reported to increase embryo survival when transfers to lactating cows are performed during periods of heat stress but to be without effect on embryonic survival when heat stress is not present (28, 22) . Similar results were obtained in the present study. In the first embryo transfer study, during which cows were exposed to heat stress, pregnancy rate at d 35 was highest for cows receiving embryos treated with IGF-I. Treatment effects were not significant but the lack of significance may represent the small number of animals used for the study. In the second embryo transfer study, conducted mostly outside the time of year when heat stress is present, there was no improvement in pregnancy rate compared with the controls. Like CSF2, IGF-I reduced pregnancy loss after d 30 -35 in both studies. Thus, this growth factor may also cause changes in preimplantation development that result in changes in postplacentation development conducive for conceptus survival.
